You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Germany

Apr 2011

Price: US$2,400

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Germany with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Germany, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Germany for free:

The Consumer Health in Germany market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Germany?
  • What are the major brands in Germany?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health in Germany stagnated in 2010

Consumer health stagnated in 2010. Whilst consumer health products showed growth over the review period from 2005 to 2009, the category stagnated in 2010 due to more consumers purchasing consumer health products in prescription format instead of OTC.

The health and wellness trend is having a negative impact on consumer health sales

The health and wellness trend has led a number of Germans to pay more attention to having a healthy diet and sufficient exercise. This trend is having a direct impact on consumer health sales, since Germans fall ill less frequently and therefore purchase less OTC medication.

Bayer Vital GmbH remains the leading manufacturer of consumer health products in Germany

Bayer Vital GmbH continued to be the leading manufacturer of consumer health products in Germany. Whilst the manufacturer lost some of its value share, it continues to lead consumer health. The company’s best-selling product in 2010 remained Bayer Aspirin.

Chemists/pharmacies continues to be the most common outlet for consumer health products

Chemists/pharmacies continues to be the leading outlet channel for consumer health sales. However, other outlet channels are gaining in importance, such as parapharmacies/drugstores, discounters and internet retailing. Online retailers are predicted to show substantial growth over the forecast period.

Consumer health sales value is predicted to decline during the forecast period

Throughout the forecast period, consumer health sales are expected to decline in constant value terms due to German consumers purchasing fewer OTC medications and more prescription medications. The health and wellness trend will also have a negative impact on consumer health sales as demand softens.

Table of Contents

Table of Contents

Consumer Health in Germany - Industry Overview

EXECUTIVE SUMMARY

Consumer health in Germany stagnated in 2010

The health and wellness trend is having a negative impact on consumer health sales

Bayer Vital GmbH remains the leading manufacturer of consumer health products in Germany

Chemists/pharmacies continues to be the most common outlet for consumer health products

Consumer health sales value is predicted to decline during the forecast period

KEY TRENDS AND DEVELOPMENTS

Increased interest in health and wellness leads to a slowdown in OTC sales

Consumer health sales through internet retailing are becoming increasingly popular

Consumer insecurities affect the consumer health category

Innovation is key for the survival of premium brands

Self-medication in Germany

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and preventative medicine

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

Sources

  • Summary 2 Research Sources

Consumer Health in Germany - Company Profiles

Bad Heilbrunner Naturheilmittel GmbH & Co in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Bad Heilbrunner Naturheilmittel GmbH & Co: Competitive Position 2010

Bayer Vital GmbH in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 8 Bayer Vital AG: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 9 Bayer Vital GmbH: Competitive Position 2010

Beiersdorf AG in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 12 Beiersdorf AG: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 13 Beiersdorf AG: Competitive Position 2010

Boehringer Ingelheim Pharma GmbH & Co KG in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 16 Boehringer Ingelheim Pharma GmbH & Co KG: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 17 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2010

GlaxoSmithKline GmbH & Co KG in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 20 GlaxoSmithKline GmbH & Co KG: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 21 GlaxoSmithKline GmbH & Co KG: Competitive Position 2010

Hartmann AG, Paul in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 24 Paul Hartmann AG: Competitive Position 2010

MCM Klosterfrau Vertriebsgesellschaft mbH in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 27 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2010

Novartis Deutschland GmbH in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 30 Novartis Deutschland GmbH: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 31 Novartis Deutschland GmbH: Competitive Position 2010

Ratiopharm GmbH & Co in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 34 Ratiopharm GmbH & Co: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 35 Ratiopharm GmbH & Co: Competitive Position 2010

STADA Arzneimittel AG in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 38 STADA Arzneimittel AG: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 39 STADA Arzneimittel AG: Competitive Position 2010

Adult Mouth Care in Germany - Category Analysis

HEADLINES

TRENDS

  • The German population pays great attention to maintaining daily mouth hygiene, something that has been a constant since their initial education received in schools and through the media. The high cost of dental treatment also is an incentive for people to maintain good mouth hygiene and avoid high dentist costs. This has resulted in less consumer demand for adult mouth care products, which continued also in 2010.

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline GmbH led adult mouth care with a value share of 17% due to the strength of its Chlorhexamed branded mouthwash for gum diseases. The product has a long history, having been launched in Germany in 1975, and enjoys high brand equity but faces stiff competition from mass-market medicinal mouthwashes. In spite of this, it was able to maintain its position due to consumer credibility and increased its value share by one percentage point in the review period.

PROSPECTS

  • Adult mouth care is expected to decline by 15% in constant value terms with a negative CAGR of 3% in the forecast period. This is mainly due to the competition posed by the high growth in mouth hygiene products with medicinal values.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Germany - Category Analysis

HEADLINES

TRENDS

  • After the packaging size of paracetamol to be sold for self-medication was restricted to 10g per package in 2009, there have been further discussions to do the same for other analgesic products. Suggestions were made to restrict the OTC packaging size of aspirin to 10g per package, ibuprofen to 8g per package and diclofenac to 500mg per package. Packages with larger quantities would be classified as prescription medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer Vital GmbH continues to be the leading manufacturer of analgesics in Germany. The company had a value share of almost 19% in 2010, which was down slightly compared to 2009 due to the weak performance of its main brand Aspirin. Aspirin lost some value share to Ratiopharm aspirin in 2010 due to the lower unit price of the latter product.

PROSPECTS

  • Throughout the forecast period, value sales of analgesic products are predicted to decline further by around 2% annually. The main reason for the decline in value sales of analgesics is the fact that products are becoming more advanced; hence smaller quantities need to be consumed. Furthermore, German consumers try to find alternative methods of treatments instead of consuming analgesics for minor pains out of fear of becoming immune to their effects and to possibly cut costs.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Germany - Category Analysis

HEADLINES

TRENDS

  • A large number of Germans suffer from sleeping disorders and high stress levels due to work and finance-related worries and busy lifestyles, particularly since the start of the latest global recession. However, many are cautious not to use sleeping and calming medications as their long-term usage may result in addiction or dependence. This led to a decline in consumer demand for the category also in 2010, which was in line with the negative CAGR in the review period.

COMPETITIVE LANDSCAPE

  • Whitehall Much GmbH had the leading position with a value share of 15% thanks to its Halbmond brand and herbal-based Baldriparan brand. The company is owned by Pfizer Inc and receives significant marketing and advertising support that helps to create strong brand equity. Baldriparan managed to increase its leading market share further in 2010.

PROSPECTS

  • Calming and sleeping products are expected to decline in constant value by 37% with a negative CAGR of 9% from 2010 to 2015. The cautious attitude of the German to such products will continue to persist also in the forecast period.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Germany - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies value sales showed a minimal decline in 2010. The main reason for the decline in value sales is the fact that the proportion of Germans treating their cough and colds with self-medication declined in comparison to the number of Germans who used prescription medication. Especially when Germans experience more severe colds, they prefer to visit their doctor to receive the most effective medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • Proctor & Gamble GmbH was the leading manufacturer of cough, cold and allergy (hay fever) remedies in 2010 with a value share of more than 10%. The leading brand is Wick, a decongestant rub, which held a value share of 34% within the decongestant rubs category. Wick was the leading cough, cold and allergy (hay fever) product over the entire review period. The product’s success stems from its easy application and the fact that it has almost no side effects, making it a useful remedy for use in children as well as adults.

PROSPECTS

  • Throughout the forecast period, cough, cold and allergy (hay fever) remedies is predicted to decline by around 1% annually. The decline in value sales of those remedies comes from the fact that German consumers are living a healthier lifestyle and therefore fall sick less frequently. Germany has also seen an increase in prescription cough and cold medication in comparison to OTC products. This trend is likely to continue throughout the forecast period.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Germany - Category Analysis

HEADLINES

TRENDS

  • The fairly new proton pump inhibitors category expanded at the end of 2009 and beginning of 2010 with the introduction of a number of new products, including Buscogast by Boehringer Ingelheim Pharma GmbH & Co KG, Omep by Hexal AG and Antra by Bayer Vital AG.

SWITCHES

COMPETITIVE LANDSCAPE

  • Boehringer Ingelheim Pharma GmbH & Co KG continued to be the leading manufacturer of digestive remedies in 2010 with a value share of 19%, even though the company experienced a slight decline in value share in 2010. Boehringer Ingelheim’s most successful brands are the laxative remedies Dulcolax and Laxoberal.

PROSPECTS

  • Throughout the forecast period from 2010 until 2015, the digestive remedies category is predicted to decline by almost 2% annually in terms of value sales. The main reason for this decline derives from the fact that the German population is continuously trying to improve their eating habits. The health and wellness trend is having a positive impact on consumers’ digestive systems.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Germany - Category Analysis

HEADLINES

TRENDS

  • Daily ear care in Germany is generally restricted to cleaning the ears with cotton buds, and Germans are used to going to the doctor to get their ears cleaned or for other ear ailments, rather than use OTC products. This lack of confidence to treat ear problems themselves continued to negatively affect the category also in 2010.

COMPETITIVE LANDSCAPE

  • In 2010, Südmedica GmbH was the leading player with a value share of 32%, thanks to its Otalgan and Otitex brands that are used to treat ear pain and swelling. The products have a wide distribution nationwide through pharmacies.

PROSPECTS

  • Ear care is expected to decline by 14% throughout the forecast period from 2010 to 2015. The category is likely to suffer further from the growing consumer attitude to general ear hygiene and ailments as things that need the attention of a physician.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Germany - Category Analysis

HEADLINES

TRENDS

  • Increasingly long working hours, and dry air in living spaces caused by air conditioning and heating as well as the environmental pollution, particularly in cities, have increased the incidence of red and dry eyes in Germany. This is driving demand amongst consumers for regular eye care to address the discomfort arising from these conditions and fuelling sales of eye care products, which grew in value by 2% in 2010, similar to the average seen over the review period.

COMPETITIVE LANDSCAPE

  • The competitive landscape is dominated by a small number of leading multinationals and domestic companies with strong brands. This can be attributed to the high level of trust and confidence in eye care products that consumers demand, which only leading companies with large advertising budgets are able to provide through brand building.

PROSPECTS

  • The eye care product category is expected to grow by 6% with a CAGR of 1% in constant value terms in the forecast period. Within this category, standard eye care is projected to have a CAGR of 1% in constant value. The lifestyle of the people and the increased environmental pollution in cities will contribute to increasing levels of dry and red eye conditions that will require the daily use of eye care.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2005-2010
  • Table 54 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 55 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 56 Eye Care Company Shares by Value 2006-2010
  • Table 57 Eye Care Brand Shares by Value 2007-2010
  • Table 58 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Germany - Category Analysis

HEADLINES

TRENDS

  • Although the consumer demand for herbal/traditional remedies continued to stumble, sales of OTC homoeopathic remedies through German pharmacies grew by 2% to €293 million in 2009. The popularity of homoeopathic remedies affected the demand for herbal/traditional products also in 2010. Positive media coverage for homoeopathic remedies also robs consumer awareness and publicity from herbal/traditional products.

COMPETITIVE LANDSCAPE

  • Sales of herbal/traditional products remain highly fragmented, with no player claiming more than 6% value share of the overall category. Although multinationals such as GlaxoSmithKline and Proctor & Gamble are present in the category, herbal/traditional products tend to be only a small part of their product ranges. Therefore the investments and advertising budgets allocated to these products tend to be too small to make an impact.

PROSPECTS

  • Herbal/traditional products is expected to decline in constant value terms by 13% with a CAGR of -3% in the forecast period. These products will continue to suffer from the stiff competition from homoeopathic products, low consumer demand due to the difficult economic climate and the low marketing activities of the leading manufacturers.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 62 Herbal/Traditional Products Company Shares 2006-2010
  • Table 63 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Germany - Category Analysis

HEADLINES

TRENDS

  • In May 2010, the haemorrhoid treatments and dermatological medicines containing the ingredient bufexamac were withdrawn from the German market. The Federal Institute for Drugs and Medical Devices in Germany decided that the ingredient has more side effects in comparison to positive benefits since it has caused allergic reactions in a number of patients.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Consumer Health GmbH led the sales in medicated skin care with a value share of almost 13%. The company’s best-performing medicated skin care brands include Fenistil and Lamisil, which in 2010 had value shares of 7% and 6% respectively.

PROSPECTS

  • Over the forecast period from 2010 to 2015, the medicated skin care category is predicted to decline by almost 1% annually in terms of value sales. The decline derives from a number of different reasons. First of all, the German population is an ageing one, so whilst certain products such as hair loss treatments will prosper, others like acne treatments and nappy (diaper) rash treatments will see a decline. Another reason for the decline in the use of medicated skin care products throughout the forecast period is the fact that products are continuously improved, so consumers have to purchase lower quantities of them. Furthermore, competition between manufacturers is driving retail prices down, leading to decline in value sales.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 68 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 69 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 70 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 71 Acne Treatments Brand Shares by Value 2007-2010
  • Table 72 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 73 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 74 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Germany - Category Analysis

HEADLINES

TRENDS

  • The smoking population in Germany has been continuously declining since the smoking ban that is enforced in most public places, restaurants and bars. Whilst the ongoing price increases and consumers’ desire to live healthier lives have also fuelled smoking cessation, demand for NRT smoking cessation aids in Germany has slowed compared to the early years of the ban and as a result, value sales of these products fell by 4% in 2010. German health organisations continue to push for NRT smoking cessation aids to be paid for by health insurance since users of NRT smoking cessation aids tend to use the products over a long period of time.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil Consumer Healthcare GmbH continued to lead value sales of NRT smoking cessation aids in 2010 with a 60% value share. The company’s product Nicorette is the leading NRT smoking cessation aids brand in Germany. The Nicorette inhalator proved to be a big success on the German market and as a result gave the Nicorette brand an innovative image.

PROSPECTS

  • Throughout the forecast period, NRT smoking cessation aids value sales are predicted to decline by more than 4% annually. The sharp decline in NRT smoking cessation aids sales derives from the fact that the smoking ban was introduced in 2007 and most smokers who were willing to quit smoking have already done so in 2007 and 2008.

CATEGORY INDICATORS

  • Table 75 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 76 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 77 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 78 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 79 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 80 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 82 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015
  • Table 83 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 84 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

OTC Triptans in Germany - Category Analysis

HEADLINES

TRENDS

  • The high cost of OTC triptans is a factor that discourages widespread usage in Germany. For example, two Naratriptan tablets cost around €10 through brick and mortar chemists/pharmacists and about €5 through some online pharmacies due to special price promotions online. OTC triptans are perceived to be overpriced by the average consumer, especially taking into account that they can be prescribed in large quantities by a health practitioner.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Plc led with a 100% monopoly share as the only product available on the German market was its brand Formigran. A pack of Formigran available on OTC contains two tablets with 2.5mg of the ingredient naratriptan. The larger pack size of Formigran continues to be prescribed by doctors. There is another product containing the legalised naratriptan ingredient which is called naramig; however, this product is not available in small pack sizes and therefore is only available on prescription.

PROSPECTS

  • OTC triptans is expected to grow in constant value by 301% with a CAGR of 32% during the forecast period. Although this seems impressive, the growth starts from a small base, OTC triptans having been launched on the German market in 2006.

CATEGORY DATA

  • Table 85 Sales of OTC Triptans: Value 2006-2010
  • Table 86 Sales of OTC Triptans: % Value Growth 2006-2010
  • Table 87 OTC Triptans Company Shares by Value 2006-2010
  • Table 88 OTC Triptans Brand Shares by Value 2007-2010
  • Table 89 Forecast Sales of OTC Triptans: Value 2010-2015
  • Table 90 Forecast Sales of OTC Triptans: % Value Growth 2010-2015

Sports Nutrition in Germany - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition products continue to be mainly consumed by regular gymgoers and athletes. The increased health consciousness of the German population and the rising number of gym memberships also helped in the growth of sports nutrition in 2010.

COMPETITIVE LANDSCAPE

  • Atlantic Multipower Germany GmbH led with a value share of 13% in 2010, thanks to its two strong brands Multipower and Champ. However, the company’s value share was hovering around the 13% mark in the review period due to the stiff competition from similar products that are sold at lower prices by drugstores and internet retailers.

PROSPECTS

  • Sports nutrition category is expected to grow by 10% in constant value with a CAGR of 2% in the forecast period. The increased health consciousness of the population, increased gym membership and the growth in types of extreme sports will support a higher consumer demand for these products.

CATEGORY DATA

  • Table 91 Sales of Sports Nutrition: Value 2005-2010
  • Table 92 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 93 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 94 Sports Nutrition Company Shares 2006-2010
  • Table 95 Sports Nutrition Brand Shares 2007-2010
  • Table 96 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 97 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015
  • Summary 40 Sports Nutrition, Category Rankings 2009

Vitamins and Dietary Supplements in Germany - Category Analysis

HEADLINES

TRENDS

  • A large amount of food products such as bread and pasta, beverages such as fruit/vegetable juices and lemonades and a high percentage of food items targeted specifically at children and the ageing are fortified. This gives rise to the consumer attitude that additional purchases of vitamins and dietary supplements are superfluous and nonessential.

SWITCHES

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • The competitive landscape of vitamins and dietary supplements is extremely fragmented due to the large number of products included. GlaxoSmithKline GmbH led the category with a value share of 9% in 2010. Its Abtei brand is the leading brand in vitamins and dietary supplements due to its large range, accounting for almost 8% value share of vitamins and dietary supplements in 2010.

PROSPECTS

  • Vitamins and dietary supplements as a whole is expected to register a decline in constant value terms over the forecast period by less than 1% to €1.6 billion by 2015. The expansion of fortified and functional foods by the food industry, as well as the bad publicity and the confusion amongst the consumers caused by the conflicting reports from the medical establishment and the provitamin lobby, will continue to damage the revenues of vitamins and dietary supplements.

CATEGORY DATA

  • Summary 41 Dietary Supplements: Brand Ranking by Positioning 2010

Weight Management in Germany - Category Analysis

HEADLINES

TRENDS

  • Within weight management, all categories except OTC obesity suffered from declining consumer demand in 2010. The rapid growth of low-priced diet and low-calorie food products in grocery outlets eroded the consumer demand for weight management items that are often too expensive for the average consumer.

SWITCHES

COMPETITIVE LANDSCAPE

  • Amway GmbH was the leading manufacturer of Weight Management products in 2010 with a value market share of 12%. The direct seller is particularly successful in the Weight Management market due to its large number of sellers that are able to give more advice to consumers than for example pharmacists. Most of the Amway sellers have used the products themselves and advertise them to friends and family so obviously there is more trust involved compared to purchasing a product in a pharmacy or over the internet.

PROSPECTS

  • Weight management is expected to decline in constant value by 10% with a negative CAGR of 2% in the forecast period. Meal replacement slimming, slimming teas and weight loss supplements are expected to experience declining sales due to falling consumer demand. These will continue to face stiff competition from the diet and low-calorie food industry.

CATEGORY DATA

  • Table 98 Sales of Weight Management: Value 2005-2010
  • Table 99 Sales of Weight Management: % Value Growth 2005-2010
  • Table 100 Weight Management Company Shares 2006-2010
  • Table 101 Weight Management Brand Shares 2007-2010
  • Table 102 Forecast Sales of Weight Management: Value 2010-2015
  • Table 103 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Germany - Category Analysis

HEADLINES

TRENDS

  • Consumers consider OTC wound care products to be more or less commodities, and this attitude creates low brand loyalty that has given rise to a large range of low-priced private label items. Sticking plasters, gauze and bandages are relatively cheap to produce and therefore are easy articles for retailers to introduce to their OTC product ranges. This erodes the market potential of the category, which affected the value growth in 2010.

COMPETITIVE LANDSCAPE

  • Beiersdorf AG was the leader with a value share of 39% thanks to the strong brand equity of Hansaplast, which is a household name in sticking plasters in Germany. Thus, in the sticking plasters/adhesive bandages category, it dominated with a value share of 65% in 2010. Its financial muscle, large advertising and promotion budget and countrywide distribution network make it a strong player. However, since 2000 the strength of the Hansaplast brand has been declining due to the emergence of low-cost private label items.

PROSPECTS

  • Wound care is expected to grow in constant value by 5% with a CAGR of 1% in the forecast period. The buoyancy of the category is expected to be created through sticking plasters/adhesive bandages and gauze, tape and other wound care products. First aid kits is expected to register negative growth, partly due to the low-value products that will continue to flood the market and partly due to the small number of new cars on the road due to a difficult economic climate in the country.

CATEGORY DATA

  • Table 104 Sales of Wound Care by Category: Value 2005-2010
  • Table 105 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 106 Wound Care Company Shares by Value 2006-2010
  • Table 107 Wound Care Brand Shares by Value 2007-2010
  • Table 108 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 109 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Artichoke
            • Hawthorn
            • Isoflavones
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Silica
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report